James J. Vaughn, Chief Commercial Officer at GENOMIC HEALTH INC (GHDX), sold 8,745 shares at $52.25 ($459K) on 2019-06-06, disclosed to the SEC on 2019-06-10.
Open-market sale of $459k GHDX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.25 | 2,600 | $136K | 29.6% |
| 2 | $52.25 | 3,604 | $188K | 41.0% |
| 3 | $52.30 | 1,400 | $73K | 16.0% |
| 4 | $53.03 | 200 | $11K | 2.3% |
| 5 | $53.06 | 370 | $20K | 4.3% |
| 6 | $54.65 | 100 |
| $5K |
| 1.2% |
| 7 | $54.65 | 271 | $15K | 3.2% |
| 8 | $54.70 | 200 | $11K | 2.4% |
| Total | $52.47 avg | 8,745 | $459K | 100% |
| Filing → |
| GHDX | SELL | 2019-05-10 | $421K | — | Filing → |
| GHDX | SELL | 2018-10-10 | $3.2M | — | Filing → |
| GHDX | SELL | 2018-06-06 | $4.3M | — | Filing → |